Shares of weight-loss drug developer Metsera jumped nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture ...
The NASDAQ-100 is widely followed as a measure mainly of the big tech and social media stocks that make up the index.
Investors react to the Federal Reserve's policy decision and Chairman Jerome Powell's press conference, as well as results ...
The S&P 500 and the Nasdaq slipped on Wednesday, as losses in tech heavyweights Apple and Nvidia pressured broader gains and ...
The tech-heavy Nasdaq 100 is the best performer but more risk-averse investors may prefer the more broadly diversified S&P ...
The Nasdaq Composite is an often-cited stock market index — along with the S&P 500 and the Dow Jones Industrial Average — ...
Maze Therapeutics became the latest drug developer to list in New York on Friday, with its shares rising nearly 1% in their debut, giving the company a valuation of $690.37 million.
The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s ...
Live Updates Technology Stocks Rising Today 2:09 pm While NVIDIA (Nasdaq: NVDA) is down 17% today, many stocks across ...
U.S. stock averages ended in the red Friday, driving lower after the Trump administration said tariffs on key U.S. trading ...